Charlie’s Holdings, Inc. (OTCMKTS:CHUC – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 50,334 shares, a growth of 168.5% from the August 15th total of 18,744 shares. Based on an average daily trading volume, of 117,672 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.0% of the company’s shares are short sold.
Charlie’s Price Performance
Charlie’s stock opened at $0.16 on Monday. The company has a market cap of $45.73 million, a price-to-earnings ratio of -16.30 and a beta of 1.35. The firm has a 50 day moving average price of $0.20 and a 200 day moving average price of $0.24. Charlie’s has a 1 year low of $0.14 and a 1 year high of $0.38. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.40 and a current ratio of 1.65.
Charlie’s (OTCMKTS:CHUC – Get Free Report) last released its quarterly earnings data on Monday, August 17th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $3.80 million for the quarter. Charlie’s had a negative return on equity of 63.51% and a negative net margin of 7.47%.
Charlie’s Company Profile
Charlie's Holdings, Inc, together with its subsidiaries, formulates, markets, and distributes non-combustible nicotine-related, alternative alkaloid vapor, and hemp-derived vapor and edible products. It sells its products through distributors, specialty retailers, and third-party online resellers in the United States, the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. Charlie's Holdings, Inc was founded in 2014 and is headquartered in Costa Mesa, California.
Featured Stories
- Five stocks we like better than Charlie’s
- Digging for Value: Alpha Metallurgical Resources Insider Buys Big
- Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
Receive News & Ratings for Charlie's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charlie's and related companies with MarketBeat.com's FREE daily email newsletter.
